Cargando…

Major Clinical Issues in Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is one of the most common inheritable cardiomyopathies. Contemporary management strategies, including the advent of implantable cardioverter-defibrillators and effective anticoagulation, have substantially improved the clinical course of HCM patients; however, the d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hyun-Jung, Kim, Jihoon, Chang, Sung-A, Kim, Yong-Jin, Kim, Hyung-Kwan, Lee, Sang Chol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2022
Materias:	State of the Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353251/ https://www.ncbi.nlm.nih.gov/pubmed/35929051 http://dx.doi.org/10.4070/kcj.2022.0159

Ejemplares similares

Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy
por: Lee, Hyun-Jung, et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy in Infants from the Perspective of Cardiomyocyte Maturation
por: Seok, Heeyoung, et al.
Publicado: (2021)

Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
por: Braunwald, Eugene, et al.
Publicado: (2023)

Determinants of Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
por: Hwang, Ji-won, et al.
Publicado: (2022)

Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure
por: Kim, Kyung-Hee, et al.
Publicado: (2021)

Sex differences in the prognosis of patients with hypertrophic cardiomyopathy
por: Kim, Minkwan, et al.
Publicado: (2021)

Issues and developments related to assessing function in serious mental illness
por: Brown, Matt A., et al.
Publicado: (2016)

2021 Korean Society of Myocardial Infarction Expert Consensus Document on Revascularization for Acute Myocardial Infarction
por: Chang, Kiyuk, et al.
Publicado: (2021)

Interventions for Adherence Improvement in the Primary Prevention of Cardiovascular Diseases: Expert Consensus Statement
por: Ihm, Sang Hyun, et al.
Publicado: (2021)

Core symptoms of major depressive disorder: relevance to diagnosis and treatment
por: Kennedy, Sidney H.
Publicado: ( 200)

Treatment strategies to improve and sustain remission in major depressive disorder
por: Madhukar H., Trivedi, et al.
Publicado: (2008)

Lifestyle Modification in the Management of Metabolic Syndrome: Statement From Korean Society of CardioMetabolic Syndrome (KSCMS)
por: Kim, Hack-Lyoung, et al.
Publicado: (2021)

Role of cardiovascular magnetic resonance imaging and cardiopulmonary exercise test in predicting composite clinical outcomes in patients with hypertrophic cardiomyopathy
por: Hwang, Ji-won, et al.
Publicado: (2023)

Genotype-Related Clinical Characteristics and Myocardial Fibrosis and Their Association with Prognosis in Hypertrophic Cardiomyopathy
por: Kim, Hyung Yoon, et al.
Publicado: (2020)

Historical Review and Future of Cardiac Xenotransplantation
por: Koh, Jiwon, et al.
Publicado: (2023)

Clinical impact of atrial fibrillation in a nationwide cohort of hypertrophic cardiomyopathy patients
por: Lee, Hyun-Jung, et al.
Publicado: (2020)

Restrictive cardiomyopathy: definition and diagnosis
por: Rapezzi, Claudio, et al.
Publicado: (2022)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
por: Park, Kyoung-min, et al.
Publicado: (2016)

Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy
por: Autore, Camillo, et al.
Publicado: (2023)

Role of Endothelium in Doxorubicin-Induced Cardiomyopathy
por: Luu, Albert Z., et al.
Publicado: (2018)

From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies
por: Crotti, Lia, et al.
Publicado: (2023)

Emergency department utilization in patients with hypertrophic cardiomyopathy: a nationwide population-based study
por: Choi, You-Jung, et al.
Publicado: (2022)

Comparison of mortality and cause of death between adults with and without hypertrophic cardiomyopathy
por: Kwon, Soonil, et al.
Publicado: (2022)

Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)

Translation of New and Emerging Therapies for Genetic Cardiomyopathies
por: Helms, Adam S., et al.
Publicado: (2021)

Cardiovascular Regeneration via Stem Cells and Direct Reprogramming: A Review
por: Lee, Choon-Soo, et al.
Publicado: (2022)

Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
por: Gasperetti, Alessio, et al.
Publicado: (2023)

Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation
por: Choi, You-Jung, et al.
Publicado: (2022)

Why does apical hypertrophic cardiomyopathy have a favorable outcome than non-apical types?: Cardiac magnetic resonance and echocardiographic findings from 350 patients with hypertrophic cardiomyopathy
por: Kim, Eun Kyoung, et al.
Publicado: (2014)

Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication
por: Kim, Jin Sug, et al.
Publicado: (2021)

Exercise and Coronary Atherosclerosis: Observations, Explanations, Relevance, and Clinical Management
por: Aengevaeren, Vincent L., et al.
Publicado: (2020)

Prevalence and characteristics of apical aneurysm on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
por: Kim, Eun Kyoung, et al.
Publicado: (2014)

PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms
por: Trusheim, MR, et al.
Publicado: (2016)

“Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?
por: Eichler, H‐G, et al.
Publicado: (2016)

Translation and Clinical Development of Bispecific T‐cell Engaging Antibodies for Cancer Treatment
por: Yuraszeck, T, et al.
Publicado: (2017)

Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases: Roadmap to the Clinic
por: Sahoo, Susmita, et al.
Publicado: (2021)

A Proposal for Integrated Efficacy-to-Effectiveness (E2E) Clinical Trials
por: Selker, H P, et al.
Publicado: (2014)

The ethics of forgoing life-sustaining treatment: theoretical considerations and clinical decision making
por: Welie, Jos VM, et al.
Publicado: (2014)

Exercise-Induced Cardiac Troponin Elevations: From Underlying Mechanisms to Clinical Relevance
por: Aengevaeren, Vincent L., et al.
Publicado: (2021)

Clinical roles of TIM-3 in myeloid malignancies and its importance in cellular therapy
por: Kikushige, Yoshikane
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_klpm73lfmr03n3nlggkb7t6tvg